Finland· FI-REL-REL10054
Emadine
A emedastine product containing emedastine, registered in Finland by Immedica Pharma AB. The same ATC class is registered in 12 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Emedastine is registered in 12 of 19 countries.
Countries holding a registration under ATC S01GX06 (emedastine), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 7 of them publish a price we can compare per daily dose
Emedastine · ATC S01GX06
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
Fimea (Finland)- Active substance
- Emedastine
- Manufacturer
- Immedica Pharma AB
- Country
- Finland (FI)
- ATC code
- S01GX06
- ATC class
- Emedastine
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Emedastine in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenEmadine 0,5 mg/ml Ögondroppar, lösningImmedica Pharma AB
- PolandEmadineImmedica Pharma AB
- United KingdomEmadine 0.5mg/ml eye dropsNecessity Supplies Ltd
- SwitzerlandEmadine
- SpainEMADINE 0,5 MG/ML COLIRIO EN SOLUCIONAlcon Laboratories Ltd (Uk)
- NorwayEmadineImmedica Pharma AB (1)
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Emadine
- Liechtenstein · Emadine
- Norway · Emadine
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/09e3f115-49e5-4240-87f8-bc5a71c05780 GET /v1/drugs/09e3f115-49e5-4240-87f8-bc5a71c05780?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "silmätipat, liuos",
"route": "Silmän pinnalle",
"ddd_unit": null,
"strength": "0.5 mg/ml",
"atc_label": "emedastiini",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/98/095/001-002",
"fimea_rel_id": "REL10054",
"authorised_at": "1999-01-27"
}See everything about emedastine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.